FDA OKs Sodium Thiosulfate for Ototoxicity Risk in Peds Cancer

This makes sodium thiosulfate the first and only FDA-approved treatment for this indication and patient population.

Related Keywords

California ,United States ,Los Angeles ,Davidr Freyer ,Fennec Pharmaceuticals ,Drug Administration ,Hospital Los Angeles ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Hepatoblastoma ,Hearing Impairment ,Hearing Loss ,Adverse Events Pharmacology ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Adverse Effects ,Side Effects ,Cancer ,Alignant Neoplasia ,Arcinoma ,Hototoxicity ,Hypernatremia ,Hypokalemia ,Nausea ,